New Discovery: A Special Subset of CD8+ T Cells May Hold the Key to HIV Cure
- Moderna Latest Study: mRNA Therapy for Treating T Cell-Mediated Autoimmune Diseases
- The Biosecure Act May Hurt Pharmaceutical Supply Chains
- Mosquito Elimination on Global Health: Unraveling the Claim of 700K Annual Deaths
- Intensive Blood Pressure Management to Below 140 mmHg Reduces Stroke Risk, Regardless of Medication Dosage
- GLP-1 Drugs: How Significant is Their Impact on Brain Health?
- Why Eel Sashimi Is Unsafe: Understanding the Risks of Consuming Raw Eel
New Discovery: A Special Subset of CD8+ T Cells May Hold the Key to HIV Cure
- Shocking! All existing AIDS vaccine developments have failed
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
New Discovery: A Special Subset of CD8+ T Cells May Hold the Key to HIV Cure
Researchers at Emory University in the United States have published a study in Nature Immunology that could significantly impact the future of HIV treatment.
The research team, led by Paiardini, identified a unique subset of CD8+ T cells—designated TOXhiTCF1+CD39+CD8 T cells—within the lymph nodes of rhesus macaques.
These cells appear to be associated with the spontaneous control of SIV, the simian counterpart of HIV, suggesting they could play a crucial role in controlling and potentially curing HIV.
The study found that while these cells express low levels of cytotoxic molecules, they highly express inhibitory molecules. This indicates that they may control the virus through mechanisms other than the conventional method of directly killing infected cells. Upon further analysis of the SIV-specific TOXhiTCF1+CD39+CD8 T cells, researchers discovered that these cells are in an intermediate state. They possess the potential to differentiate into terminal effector T cells while also retaining stem cell-like properties, possibly allowing them to sustain the immune response over the long term. Additionally, these cells are more frequently distributed in lymphoid follicles compared to other cell types and tend to cluster near cells containing SIV RNA. This proximity may enhance their ability to monitor and control viral replication more effectively.
The presence of these cells was found to be negatively correlated with plasma viral load and the size of the viral reservoir, implying that an increase in these cells could be associated with effective viral control. Notably, the phenotypic characteristics of these cells were consistent in both untreated animals and those receiving antiretroviral therapy (ART). This suggests that these cells might have a universal role in controlling SIV (or HIV) infection, whether in natural controllers (EC) or in individuals who manage the virus post-treatment (PTC).
In summary, this research not only advances our understanding of HIV immune control but also opens new avenues for future HIV treatment strategies. By further investigating the mechanisms by which these TOXhiTCF1+CD39+CD8 T cells function, scientists may develop more effective methods to control or even cure HIV infection. However, these findings must be validated in humans, and additional research is needed to determine the most effective way to harness these cells for HIV treatment.
Summary:
This discovery is significant for understanding the natural control of HIV and developing new therapeutic approaches. First, it identifies a novel immune cell subset that could play a key role in controlling HIV infection. Second, it provides a target for developing new immunotherapies that could enhance patients’ immune responses by boosting the function or production of these cells. Lastly, this research offers new directions for exploring HIV cure strategies, particularly in leveraging these cells’ properties to design more effective treatments.
New Discovery: A Special Subset of CD8+ T Cells May Hold the Key to HIV Cure
References:
1、Lymphoid TCF1+CD39+CD8+ T cells maintain stem-like features and contribute to viral control
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
